Compare Agilent Technologies Inc (A) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs State Street Technology Select Sector SPDR ETF — how do they compare? Agilent Technologies Inc trades at $149.08 (market cap $43.30B), while State Street Technology Select Sector SPDR ETF trades at $183.41. The key difference: Agilent Technologies Inc pays a 0.66% dividend while State Street Technology Select Sector SPDR ETF pays none. Which is the better fit depends on your goals.
| A | XLK | |
|---|---|---|
Market Cap | $43.30B | — |
Sector | Health | Sector/Thematic |
52-Week High | $158.93 | $198.21 |
52-Week Low | $110.24 | $127.49 |
Enterprise Value | $45.49B | — |
Dividend Yield | 0.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $149.42, down 2.88% on the day, with strong fundamental performance including Q3 2026 earnings beat of $1.62 per share versus $1.49 estimate. The company reported 8.1% revenue growth and raised full-year guidance, reflecting improving demand for lab tools and diagnostics equipment. Technical indicators show a bullish trend with moving averages supporting upward momentum, while RSI levels remain neutral.
The outlook remains positive with 77.5% analyst buy ratings and a $174.77 consensus price target representing 17% upside. Key risks include execution challenges in international markets and competitive pressures in the medical equipment sector. Recent institutional buying activity and strong cash flow generation support the bullish thesis.
XLK (Technology Select Sector SPDR ETF) trades at $183.64, down 1.13% on the day, with a bullish technical signal driven by moving averages. The ETF shows neutral momentum oscillators, with RSI at 45.56 indicating no overbought or oversold conditions. Recent news highlights strong inflows into tech ETFs amid AI-driven sector shifts, though software sustainability concerns persist due to reliance on price increases rather than new customer growth.
The outlook for XLK remains positive given tech earnings strength and AI tailwinds, but risks include sector concentration, valuation pressures, and macroeconomic sensitivity. Wall Street analysts favor broad tech exposure via XLK for its liquidity and growth alignment, though competition from lower-cost alternatives like IGM warrants monitoring for diversification benefits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →
